Emcure Pharma IPO: Namita Thappar On Tie Up With Sanofi & In-House Products For Cardiac Segment
ฝัง
- เผยแพร่เมื่อ 2 ก.ค. 2024
- Namita Thappar, in association with Sanofi, has strategically partnered for Emcure Pharmaceuticals, aiming to leverage their combined expertise in cardiovascular healthcare. Additionally, she is spearheading the development of innovative in-house products dedicated to enhancing cardiovascular treatments, thereby reinforcing Emcure Pharmaceuticals' commitment to advancing healthcare solutions.
#emcurepharma #namitathapar #ipo
-------------------------------------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: / @ndtvprofitindia
Visit NDTV Profit for more news: www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit.com/research-r...
Follow NDTV Profit here
Twitter: / ndtvprofitindia , / ndtvprofit
LinkedIn: / ndtvprofit
Instagram: / ndtvprofit
Facebook: / ndtvprofit